Valuation : Psychemedics Corporation

Market Cap 97.91L 84.3L 79.16L 72.26L 1.36Cr 93Cr 1.37Cr 9.38Cr 3.65Cr 47Cr 3.68Cr 3.6Cr 156.42Cr P/E 2023
-4.09x
P/E 2024 -7x
Enterprise Value 95.4L 82.14L 77.13L 70.4L 1.32Cr 91Cr 1.33Cr 9.14Cr 3.56Cr 46Cr 3.58Cr 3.5Cr 152.41Cr EV / Sales 2023
0.79x
EV / Sales 2024 0.68x
Free-Float
44.15%
Yield 2023
2.36%
Yield 2024 -
1 day+13.18%
3 months+3.75%
6 months+66.00%
Current year+55.62%
Current year 1.33
Extreme 1.33
2.7
1 year 1.33
Extreme 1.33
2.7
3 years 1.11
Extreme 1.11
4.3
5 years 1.11
Extreme 1.11
8.9
10 years 1.11
Extreme 1.11
27.99
Manager TitleAgeSince
Chief Executive Officer 59 17/08/2023
Director of Finance/CFO 36 27/11/2023
Corporate Officer/Principal 40 21/09/2023
Director TitleAgeSince
Director/Board Member 64 16/03/2021
Director/Board Member 58 04/04/2022
Director/Board Member 64 12/08/2022
Date Insider Type Main position Quantity % Market Cap. Importance
13/12/24
Powell Anderson Capital Partners
BuyCompany 1,59,700 2.7093%
10/12/24
Powell Anderson Capital Partners
BuyCompany 86,991 1.4758%
10/12/24 Sell

Director

3,20,708 5.4408%
Change 5-day change 1-year change 3-year change Capi.($)
+13.18%-.--%+15.28%-40.29% 1.52Cr
-1.32%-1.76%+90.13%+448.20% 4.7TCr
-0.73%-1.09%+19.67%+56.65% 2.72TCr
-2.25%-7.07%-18.54%-39.37% 710.47Cr
+1.62%+1.51%+7.84%+126.94% 587.16Cr
+0.18%+2.13%+16.93%+75.12% 337.55Cr
-1.77%-0.45%-33.84%+1,805.84% 257.47Cr
-0.78%+9.14%+103.29%+19.16% 231.9Cr
+5.35%+5.98%+28.04%+33.33% 196.96Cr
-0.15%-12.66%-14.30%-55.06% 188.8Cr
Average +1.44%-0.80%+21.45%+243.05% 993.24Cr
Weighted average by Cap. -0.35%-1.36%+49.59%+281.83%

Financials

2023 2024
Net sales 2.21Cr 1.9Cr 1.79Cr 1.63Cr 3.06Cr 210.26Cr 3.09Cr 21Cr 8.24Cr 106.62Cr 8.3Cr 8.12Cr 353.03Cr 1.97Cr 1.69Cr 1.59Cr 1.45Cr 2.73Cr 187.3Cr 2.75Cr 19Cr 7.34Cr 95Cr 7.39Cr 7.23Cr 314.48Cr
Net income -41.54L -35.77L -33.58L -30.66L -57.59L -40Cr -58L -3.98Cr -1.55Cr -20Cr -1.56Cr -1.53Cr -66Cr -18.61L -16.02L -15.05L -13.73L -25.8L -18Cr -25.99L -1.78Cr -69.37L -8.98Cr -69.87L -68.36L -30Cr
Net Debt 3L 3L 3L 2L 5L 3.18Cr 5L 32L 12.45L 1.61Cr 12.54L 12.27L 5.34Cr -3L -2L -2L -2L -3L -2.39Cr -4L -24.05L -9L -1.21Cr -9L -9L -4.01Cr
Logo Psychemedics Corporation
Psychemedics Corporation is a hair drug testing company. The Company provides testing services for the detection of drugs of abuse through the analysis of hair samples. Its testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The Company customizes its enzyme immunoassay (EIA) procedures to drug test hair samples. It provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines (including ecstasy, eve, and Adderall), opiates (including heroin, hydrocodone, hydromorphone, oxycodone and codeine), synthetic cannabinoids (including K2, Spice, Blaze), benzodiazepines (Xanax, Valium, and Ativan), nicotine, Fentanyl, and alcohol. The Company markets its corporate drug testing services through its own sales force, distributors, and partners. It markets its home drug testing service, PDT-90, through the Internet.
Employees
101
  1. Stock Market
  2. Stocks
  3. PMDI Stock